Unknown

Dataset Information

0

Organometallic small molecule kinase inhibitors - direct incorporation of Re and 99mTc into Opaganib®.


ABSTRACT: [(η5-Cp)ReI(CO)3] was incorporated into the kinase inhibitor Opaganib®. The resulting bioorganometallic complex showed a similar anti-cancer activity to Opaganib® against PC-3 cancer cells. The IC50 value for the kinase SK2 is 30x higher than that of Opaganib®. The 99mTc homologue was synthesized, completing a matched-pair for molecular theranostics.

SUBMITTER: Lengacher R 

PROVIDER: S-EPMC8658909 | biostudies-literature |

REPOSITORIES: biostudies-literature

Similar Datasets

| S-EPMC3170819 | biostudies-literature
| S-EPMC4289024 | biostudies-literature
| S-EPMC9329312 | biostudies-literature
| S-EPMC6405915 | biostudies-literature
| S-EPMC4523865 | biostudies-other
| S-EPMC4111673 | biostudies-literature
| S-EPMC2823991 | biostudies-literature
| S-EPMC3892196 | biostudies-literature
| S-EPMC3225989 | biostudies-literature
| S-EPMC6759856 | biostudies-literature